| Literature DB >> 28817073 |
William de Wildt1, Huub Kooijman2, Carel Funke3, Bülent Üstün4, Afranina Leika5, Maarten Lunenburg6, Frans Kaspersen7, Edwin Kellenbach8.
Abstract
Fondaparinux sodium is a synthetic pentasaccharide representing the high affinity antithrombin III binding site in heparin. It is the active pharmaceutical ingredient of the anticoagulant drug Arixtra®. The single crystal X-ray structure of Fondaparinux sodium is reported, unequivocally confirming both structure and absolute configuration. The iduronic acid adopts a somewhat distorted chair conformation. Due to the presence of many sulfur atoms in the highly sulfated pentasaccharide, anomalous dispersion could be applied to determine the absolute configuration. A comparison with the conformation of Fondaparinux in solution, as well as complexed with proteins is presented. The content of the solution reference standard was determined by quantitative NMR using an internal standard both in 1999 and in 2016. A comparison of the results allows the conclusion that this method shows remarkable precision over time, instrumentation and analysts.Entities:
Keywords: Arixtra®; Fondaparinux sodium; extended physicochemical characterization; iduronic acid conformation; qNMR; reference standard; single crystal X-ray structure
Mesh:
Substances:
Year: 2017 PMID: 28817073 PMCID: PMC6152090 DOI: 10.3390/molecules22081362
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Structural formula of the synthetic anticoagulant pentasaccharide Fondaparinux sodium. The anomeric D1 and F1 protons used for qNMR integration have been indicated in red.
Figure 2Example of the 500 MHz 1H-NMR spectrum of a mixture of the Fondaparinux sodium standard and maleic acid in D2O with the relevant integrated signals.
Figure 3Comparison of the observed powder diffraction patterns of amorphous (green) and crystallized Fondaparinux (blue) with the pattern calculated from the single-crystal structure (red). The patterns are given an arbitrary displacement along the intensity axis to aid comparison. For the calculated pattern, the unit-cell parameters were refined using the Rietveld method to allow for the difference in data collection temperature. The reflection positions of observed and calculated patterns show a good correlation. The relative intensities show some differences, which are most likely due to the limited number of crystallites in the powder measurement, some preferred orientation effects and small changes in structure (especially in the water molecules) due to the temperature difference.
Figure 4Polarized light microscopic picture at 40× magnification of Fondaparinux crystals formed from a water/ethanol solution.
Figure 5Perspective drawing of part of the asymmetric unit of the crystal structure of Fondaparinux. Sodium ions and water molecules (coordinated and non-coordinated) are excluded for clarity. Rings and atoms mentioned in the discussion are labelled. The bonds defining the glycosidic conformation are highlighted in pink. Hydrogen bonds are marked with dashed lines. N3-H3N donates a hydrogen bond to a translation related Fondaparinux molecule (x − 1, y, z − 1). The involved symmetry positions are indicated with a *. Hydroxyl O16 donates a hydrogen bond to a water molecule not shown.
Cremer & Pople puckering parameters for the rings in the Fondaparinux structure published here (FP). Parameters for a selection of ideal conformations are included for comparison in a separate section; k is an integer number [27]. For comparison, the values calculated from the published coordinates of a selection of co-crystals of proteins and heparin. These are indicated with their PDB codes: 2GD4 is antithrombin S195A with heparin [5]; 4R9W is platelet factor 4 with heparin [7], 4X7R is wall teichoic acid glycosyl transferase [8]. The last column reports the values calculated from the coordinates of a solution NMR study [28]. 2GD4 and 4X7R contain two crystallographically independent heparin molecules; values for both are included.
| θ | ϕ | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chair | 0 or 180 | (any value) | ||||||||||||
| Half-chair | 50.8 or 129.2 | |||||||||||||
| Boat | 90 | |||||||||||||
| Skew-boat | 90 | |||||||||||||
| 0 | 349 | 7 | 64 | 7 | 65 | 12 | 308 | 7 | 0 | 6 | 342 | 4 | 26 | |
| 8 | 23 | 3 | 94 | 3 | 92 | 18 | 40 | 8 | 339 | 1 | 350 | 5 | 22 | |
| 0 | 227 | 7 | 76 | 7 | 76 | 7 | 7 | 5 | 21 | 4 | 18 | 7 | 107 | |
| 165 | 135 | 91 | 140 | 91 | 140 | 90 | 1 | 169 | 142 | 170 | 109 | 92 | 133 | |
| 4 | 298 | 7 | 268 | 7 | 268 | 89 | 208 | 5 | 28 | 14 | 68 | 10 | 324 | |
Figure 6A comparison of the conformations of the iduronic acid G ring structures in uncomplexed Fondaparinux (a) and Fondaparinux co-crystallized with antithrombin (b); from PDB entry 2GD4) [5].
Description of the overall conformation of the pentasaccharide in terms of torsion angles (deg.) of the C–O backbone in the glycosidic links (see also Figure 5 where these backbones are highlighted) and dihedral angles (deg.) between least-squares planes fitted through the ring atoms. Atom and ring labels are given in Figure 5; s.u.’s are included in parentheses. For comparison, the values for various other structures are included in the Table, see the legend of Figure 1 for details of the abbreviations used here.
| Torsion Angles (deg) | FP | 2GD4 1 | 2GD4 2 | 4R9W | 4X7R 1 | 4X7R 2 | NMR Solution |
|---|---|---|---|---|---|---|---|
| τ(O7–C1–O1–C10) | 90.0(9) | 101.4 | 101.4 | 69.5 | 96.4 | 95.5 | 76.9 |
| τ(C1–O1–C10–C11) | −143.9(10) | −157.6 | −158.0 | −155.4 | −128.2 | −126.1 | −151.4 |
| τ(O17–C7–O12–C16) | −82.3(7) | −84.4 | −84.3 | −70.2 | −94.6 | −93.0 | −55.2 |
| τ(C7–O12–C16–C17) | −103.4(6) | −120.8 | −121.0 | −105.1 | −100.5 | −97.2 | −111.0 |
| τ(O30–C13–O18–C22) | 88.5(7) | 63.1 | 62.4 | 71.0 | 73.2 | 73.7 | 89.2 |
| τ(C13–O18–C22–C23) | −145.9(6) | −157.0 | −156.2 | −132.0 | −152.0 | −146.2 | −143.8 |
| τ(O39–C19–O31–C28) | −72.0(7) | −67.8 | −-67.5 | −77.0 | −65.2 | −66.6 | −73.0 |
| τ(C19–O31–C28–C29) | −118.7(6) | −108.5 | −108.7 | −139.2 | −106.8 | −110.2 | −134.0 |
| χ (D,E) | 57.4(5) | 57.4 | 57.6 | 63.1 | 48.9 | 44.6 | 58.2 |
| χ (D,H) | 14.0(3) | 71.3 | 71.4 | 31.7 | 13.6 | 12.7 | 30.3 |
| χ (E,F) | 57.3(5) | 35.7 | 35.5 | 68.9 | 48.4 | 50.2 | 69.3 |
| χ (F,G) | 66.6(4) | 78.8 | 78.8 | 89.7 | 69.7 | 72.2 | 84.0 |
| χ (G,H) | 39.3(4) | 33.8 | 33.7 | 20.7 | 57.0 | 53.4 | 3.4 |
Geometric details of selected hydrogen bonds (Å, deg.). Standard uncertainties are given in parentheses (only available for D...A since H atoms were not freely refined). Hydrogen bond type refers to intramolecular or intermolecular hydrogen bonds. The listed hydrogen bonds are also indicated in Figure 5.
| Involved Atoms | Type | H… | |||
|---|---|---|---|---|---|
| N1–H1N…O14 | intra | 0.92 | 2.52 | 3.282(14) | 141 |
| N2–H2N…O32 | intra | 0.92 | 2.18 | 3.095(9) | 172 |
| N3–H3N…O2 ( | inter | 0.92 | 2.26 | 2.972(12) | 134 |
| O16–H16H…O76 (water) | inter | 0.84 | 1.91 | 2.54(3) | 131 |
Acquisition and processing settings of the qNMR experiment.
| Acquisition | 1999 | 2016 |
|---|---|---|
| Spectral frequency | 400 MHz | 500 MHz |
| Probe | 5 mm QNP probe | TCI Cryo Probe |
| Temperature | 25 °C/298 K | |
| Spinning | 20 Hz | Off |
| Flip angle | 60° | |
| Relaxation delay | 30 s | |
| Dummy scans | 4 | 2 |
| Number of scans | 128 | 32 |
| Number of data points | 64 k | |
| Processing | ||
| Exponential line-broadening | 0.5 Hz | 0.3 Hz |
| Zero-Filling | 64 k | 132 k |
XRPD settings.
| XRPD Settings | |
|---|---|
| X-ray | 40 kV, 15 mA |
| Goniometer | MiniFlex 600 |
| Wavelength | Cu Kα (1.541 Å) |
| Filter | Kβ(Ni) |
| Scan speed/Duration time | 2.0000 deg/min |
| Step width | 0.0200 deg |
| Scan axis | θ/2-θ |
| Scan range | 3.0000–40.0000 °C ambient |
| Temperature | Ambient |
Crystallographic data. Unit cell parameters are listed in Table 5.
| Crystal Data | |
|---|---|
| Formula | [C31H44N3O49S8]9−·9Na+·32H2O |
| Molecular weight | 2282.60 |
| Crystal system | monoclinic |
| Space group | |
| 1.784 | |
| 2 | |
| 2380 | |
| µ (Mo | 0.401 |
| Crystal size | 0.2 × 0.3 × 0.3 |
| Data collection | |
| 150 | |
| θmin, θmax, deg | 1.00, 27.49 |
| Wavelength (Mo | 0.71073 (graphite monochromated) |
| Distance crystal to detector, mm | 45 |
| X-ray exposure time, h | 7.0 |
| Refined mosaicity, deg | 0.914(1) |
| Data set (hkl-range) | −13:13, −29:29, −24:24 |
| Completeness at sin θ/λ = 0.6 Å−1 | 100.0% (no refl. missing) |
| Total data | 81362 ( |
| Total unique data | 19366 ( |
| Refinement | |
| No. of refined parameters | 1114 |
| 0.2211 | |
| 0.0786 [for 16915 | |
| 1.041 | |
| σ2( | |
| (Δ/σ)av, (Δ/σ)max | <0.0001, 0.0002 |
| Δρmin, Δρmax, e Å−3 | −0.84, 1.87 (near Na) |
Unit cell parameters of Fondaparinux determined for the single-crystal study, the cell check of a second batch, and the powder diffraction study. In all cases systematic absences indicate the space group is P21. s.u.’s are included in parentheses.
| Single Crystal (DW1623B) | Cell Check (DW1637A) | Powder | |
|---|---|---|---|
| 10.0296(2) | 10.0132(18) | 10.144(3) | |
| 23.0353(6) | 23.067(5) | 22.992(5) | |
| 18.9666(7) | 18.820(3) | 18.626(6) | |
| β, deg | 104.1420(14) | 103.731(2) | 102.65(2) |
| 4249.1(2) | 4222.6(2) | 4238.8(4) | |
| Refined mosaicity, deg | 0.914(1) | 1.626(9) | - |
| 150 | 150 | ambient |